1.2904
price down icon0.31%   -0.0196
 
loading
Therapeuticsmd Inc stock is traded at $1.2904, with a volume of 31,315. It is down -0.31% in the last 24 hours and up +22.06% over the past month. TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
See More
Previous Close:
$1.31
Open:
$1.33
24h Volume:
31,315
Relative Volume:
0.19
Market Cap:
$15.04M
Revenue:
$996.00K
Net Income/Loss:
$-6.09M
P/E Ratio:
-2.4347
EPS:
-0.53
Net Cash Flow:
$-9.76M
1W Performance:
+11.62%
1M Performance:
+22.06%
6M Performance:
+7.05%
1Y Performance:
-16.55%
1-Day Range:
Value
$1.28
$1.3399
1-Week Range:
Value
$1.15
$1.37
52-Week Range:
Value
$0.70
$2.44

Therapeuticsmd Inc Stock (TXMD) Company Profile

Name
Name
Therapeuticsmd Inc
Name
Phone
561-961-1900
Name
Address
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Name
Employee
1
Name
Twitter
@TherapeuticsMD
Name
Next Earnings Date
2025-03-31
Name
Latest SEC Filings
Name
TXMD's Discussions on Twitter

Compare TXMD with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
TXMD
Therapeuticsmd Inc
1.2994 15.16M 996.00K -6.09M -9.76M -0.53
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
146.84 65.38B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.15 44.75B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.135 40.97B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
19.96 22.50B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
411.18 19.04B 3.08B 1.24B 1.07B 25.61

Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-07-20 Downgrade Jefferies Hold → Underperform
May-19-20 Downgrade JP Morgan Overweight → Neutral
Dec-02-19 Initiated Guggenheim Buy
Oct-17-19 Initiated H.C. Wainwright Buy
Apr-30-19 Resumed Noble Capital Markets Outperform
Jun-15-18 Initiated JP Morgan Overweight
Sep-08-17 Initiated Morgan Stanley Equal-Weight
Jul-11-17 Upgrade Oppenheimer Perform → Outperform
May-09-17 Downgrade Oppenheimer Outperform → Perform
Nov-22-16 Resumed Jefferies Buy
Nov-22-16 Initiated Oppenheimer Outperform
Nov-07-16 Resumed Guggenheim Buy
Apr-04-16 Initiated Goldman Buy
Dec-08-15 Reiterated Jefferies Buy
Dec-08-15 Reiterated Stifel Buy
Sep-21-15 Reiterated Jefferies Buy
Jun-09-15 Initiated Guggenheim Buy
Jul-08-14 Initiated FBR Capital Outperform
Apr-17-14 Reiterated Noble Financial Buy
Jan-28-14 Reiterated Noble Financial Buy
View All

Therapeuticsmd Inc Stock (TXMD) Latest News

pulisher
04:39 AM

How TherapeuticsMD Inc. (29TA) stock correlates with oil marketsSwing Trade & Accurate Intraday Trading Signals - newser.com

04:39 AM
pulisher
04:20 AM

Why TherapeuticsMD Inc. stock remains a top recommendationQuarterly Earnings Report & Technical Entry and Exit Alerts - newser.com

04:20 AM
pulisher
04:02 AM

Can TherapeuticsMD Inc. stock surprise with earnings upside2025 Growth vs Value & AI Enhanced Trading Signals - newser.com

04:02 AM
pulisher
04:01 AM

What MACD and RSI say about TherapeuticsMD Inc.2025 Performance Recap & AI Powered Buy/Sell Recommendations - newser.com

04:01 AM
pulisher
03:28 AM

Can a trend reversal in TherapeuticsMD Inc. lead to recoveryInflation Watch & Real-Time Buy Signal Alerts - newser.com

03:28 AM
pulisher
03:28 AM

Why TherapeuticsMD Inc. stock is seen as undervalued2025 Analyst Calls & Reliable Volume Spike Alerts - newser.com

03:28 AM
pulisher
01:56 AM

Key metrics from TherapeuticsMD Inc.’s quarterly dataJuly 2025 WrapUp & Verified Chart Pattern Trade Signals - newser.com

01:56 AM
pulisher
01:34 AM

Will TherapeuticsMD Inc. stock benefit from upcoming earnings reportsMarket Trend Summary & Risk Managed Investment Signals - newser.com

01:34 AM
pulisher
Oct 27, 2025

How to build a dashboard for TherapeuticsMD Inc. stockWeekly Earnings Recap & Weekly Top Gainers Trade List - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Why ETFs are accumulating TherapeuticsMD Inc. (29TA) stockDay Trade & AI Enhanced Execution Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

How to read the order book for TherapeuticsMD Inc.Earnings Miss & Real-Time Volume Triggers - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Why Jiayin Group Inc. Depositary Receipt stock attracts strong analyst attention - newser.com

Oct 27, 2025

Therapeuticsmd Inc Stock (TXMD) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Therapeuticsmd Inc Stock (TXMD) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Walker Marlan D
Chief Executive Officer
Apr 14 '25
Buy
1.00
490
489
73,639
Walker Marlan D
Chief Executive Officer
Apr 10 '25
Buy
0.86
1,167
1,000
73,149
Walker Marlan D
Chief Executive Officer
Apr 09 '25
Buy
0.87
1,136
994
71,982
Collins Cooper C.
Director
Feb 18 '25
Option Exercise
0.00
8,500
0
60,516
Naughton Gail K
Director
Feb 18 '25
Option Exercise
0.00
8,500
0
8,500
Thompson Tommy G
Director
Feb 18 '25
Option Exercise
0.00
8,500
0
14,454
Walker Marlan D
Chief Executive Officer
Feb 18 '25
Option Exercise
0.00
8,281
0
70,846
$47.91
price down icon 0.61%
$22.04
price down icon 1.06%
$10.40
price down icon 0.24%
drug_manufacturers_specialty_generic RDY
$14.65
price up icon 1.24%
$148.94
price up icon 0.02%
$411.18
price down icon 2.28%
Cap:     |  Volume (24h):